X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28211) 28211
Newsletter (344) 344
Magazine Article (193) 193
Book Chapter (101) 101
Newspaper Article (70) 70
Book / eBook (37) 37
Reference (20) 20
Web Resource (17) 17
Book Review (14) 14
Conference Proceeding (11) 11
Transcript (10) 10
Publication (8) 8
Dissertation (4) 4
Report (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25416) 25416
antipsychotic agents - adverse effects (18272) 18272
male (14279) 14279
antipsychotic agents - therapeutic use (14023) 14023
psychiatry (13796) 13796
female (13187) 13187
adult (11025) 11025
schizophrenia - drug therapy (9536) 9536
schizophrenia (9359) 9359
middle aged (8124) 8124
pharmacology & pharmacy (6711) 6711
aged (4805) 4805
antipsychotic agents - administration & dosage (4681) 4681
antipsychotic drugs (4329) 4329
treatment outcome (4165) 4165
adolescent (3830) 3830
neurosciences (3698) 3698
clinical neurology (3597) 3597
olanzapine (3588) 3588
risperidone (3451) 3451
double-blind (3341) 3341
antipsychotics (3209) 3209
psychotic disorders - drug therapy (3069) 3069
clozapine (2948) 2948
risk factors (2916) 2916
psychotropic drugs (2835) 2835
drug therapy (2807) 2807
schizophrenic psychology (2645) 2645
psychiatric status rating scales (2470) 2470
atypical antipsychotics (2424) 2424
dose-response relationship, drug (2385) 2385
drugs (2325) 2325
drug therapy, combination (2305) 2305
haloperidol (2272) 2272
clozapine - adverse effects (2174) 2174
bipolar disorder - drug therapy (2105) 2105
risperidone - adverse effects (2068) 2068
young adult (1963) 1963
antipsychotic agents - pharmacology (1917) 1917
risperidone - therapeutic use (1913) 1913
animals (1893) 1893
double-blind method (1874) 1874
bipolar disorder (1849) 1849
neuroleptics (1837) 1837
risk (1743) 1743
efficacy (1682) 1682
clozapine - therapeutic use (1668) 1668
care and treatment (1649) 1649
research (1627) 1627
aripiprazole (1623) 1623
mental disorders (1614) 1614
child (1605) 1605
benzodiazepines - adverse effects (1581) 1581
benzodiazepines - therapeutic use (1579) 1579
mental disorders - drug therapy (1529) 1529
psychosis (1517) 1517
analysis (1479) 1479
prevalence (1477) 1477
schizophrenia - diagnosis (1456) 1456
retrospective studies (1400) 1400
aged, 80 and over (1373) 1373
quetiapine fumarate (1338) 1338
medicine & public health (1334) 1334
time factors (1331) 1331
antipsychotic agents (1311) 1311
medicine, general & internal (1286) 1286
dyskinesia, drug-induced - etiology (1236) 1236
dosage and administration (1231) 1231
psychology, clinical (1226) 1226
antidepressants (1223) 1223
benzodiazepines (1218) 1218
quetiapine (1216) 1216
haloperidol - adverse effects (1215) 1215
drug administration schedule (1186) 1186
piperazines - therapeutic use (1145) 1145
follow-up studies (1127) 1127
health aspects (1125) 1125
weight gain - drug effects (1118) 1118
piperazines - adverse effects (1115) 1115
antipsychotic (1112) 1112
antidepressive agents - therapeutic use (1077) 1077
dementia (1077) 1077
randomized controlled trials as topic (1059) 1059
complications and side effects (1034) 1034
internal medicine (1029) 1029
safety (1019) 1019
dopamine (1018) 1018
drug interactions (1004) 1004
basal ganglia diseases - chemically induced (1001) 1001
clinical trials (997) 997
psychopharmacology (979) 979
antipsychotic agents - pharmacokinetics (975) 975
children (971) 971
comorbidity (960) 960
prospective studies (951) 951
patients (949) 949
schizophrenia - complications (949) 949
severity of illness index (940) 940
depression (938) 938
dibenzothiazepines - adverse effects (928) 928
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (26) 26
Online Resources - Online (17) 17
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Providence Healthcare - Stacks (2) 2
Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Gerstein Science - Periodical Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27038) 27038
German (656) 656
French (574) 574
Spanish (204) 204
Japanese (197) 197
Dutch (172) 172
Russian (120) 120
Portuguese (78) 78
Polish (73) 73
Italian (70) 70
Danish (62) 62
Norwegian (51) 51
Chinese (43) 43
Swedish (41) 41
Hungarian (38) 38
Finnish (24) 24
Turkish (24) 24
Hebrew (23) 23
Czech (16) 16
Romanian (10) 10
Serbian (5) 5
Lithuanian (3) 3
Bulgarian (2) 2
Greek (2) 2
Korean (2) 2
Croatian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Internal Medicine, ISSN 0953-6205, 2014, Volume 25, Issue 10, pp. 900 - 908
Abstract Background Patients with chronic diseases often receive multiple medications and are associated with increased vulnerability to medication errors.... 
Internal Medicine | Safety management/organization and administration | High-alert medications | Patient safety | Chronic patient | Medication errors/prevention and control | EMERGENCY-DEPARTMENT VISITS | HOSPITAL ADMISSIONS | UNIT | ADVERSE DRUG EVENTS | SAFETY | RISK | PREVALENCE | CARE | OLDER PERSONS | MEDICINE, GENERAL & INTERNAL | PRESCRIPTIONS | Digoxin - adverse effects | Drug-Related Side Effects and Adverse Reactions - prevention & control | Antipsychotic Agents - adverse effects | Humans | Sodium Potassium Chloride Symporter Inhibitors - adverse effects | Mineralocorticoid Receptor Antagonists - adverse effects | Amiodarone - analogs & derivatives | Adrenal Cortex Hormones - adverse effects | Amiodarone - adverse effects | Cytostatic Agents - adverse effects | Methotrexate - adverse effects | Analgesics, Opioid - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anticonvulsants - adverse effects | Anti-Arrhythmia Agents - adverse effects | Adrenergic beta-Antagonists - adverse effects | Immunosuppressive Agents - adverse effects | Benzodiazepines - adverse effects | Spironolactone - analogs & derivatives | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Spironolactone - adverse effects | Chronic Disease - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Drugs | Chronic diseases
Journal Article
Journal Article
JAMA psychiatry (Chicago, Ill.), ISSN 2168-622X, 05/2015, Volume 72, Issue 5, pp. 438 - 445
IMPORTANCE: Antipsychotic medications are associated with increased mortality in older adults with dementia, yet their absolute effect on risk relative to no treatment or an alternative psychotropic is unclear. OBJECTIVE... 
MORTALITY | MEDICATIONS | METAANALYSIS | EFFICACY | PSYCHIATRY | ALZHEIMERS-DISEASE | NEUROPSYCHIATRIC SYMPTOMS | OLDER-ADULTS | DRUGS | PLACEBO-CONTROLLED TRIALS | ATYPICAL ANTIPSYCHOTICS | United States - epidemiology | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Risk | Case-Control Studies | Dose-Response Relationship, Drug | Psychotropic Drugs - adverse effects | Dibenzothiazepines - adverse effects | Risperidone - adverse effects | Female | Registries | Retrospective Studies | Dementia - drug therapy | Quetiapine Fumarate | Veterans - psychology | Psychotropic Drugs - administration & dosage | Haloperidol - adverse effects | Dementia - mortality | Antipsychotic Agents - administration & dosage | Aged | Benzodiazepines - adverse effects | Veterans - statistics & numerical data | Antidepressive Agents - adverse effects | Dosage and administration | Antipsychotic drugs | Mortality | Analysis | Risk factors | Dementia | Veterans | Comorbidity | Americans | Survivors | Outpatient Treatment | Longitudinal Study | Psychiatric Disorders | Epidemiology | Benzodiazepines | Conventional Antipsychotics | Anticonvulsants | Cognitive Disorders | Etiology | Psychopharmacology | Opioids | Aging | Antidepressant Drugs | Atypical Antipsychotics | PTSD (ICD-9) | Negative Therapeutic Reaction
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 10/2009, Volume 302, Issue 16, pp. 1765 - 1773
Journal Article
Harvard Review of Psychiatry, ISSN 1067-3229, 9/2011, Volume 19, Issue 5, pp. 240 - 258
Background: This project aimed to provide an organized, sequential, and evidence-supported approach to the pharmacotherapy of posttraumatic stress disorder... 
Stress disorders | Posttraumatic stress disorder | Algorithms | Psychopharmacology | algorithms | stress disorders | PLACEBO-CONTROLLED-TRIAL | PSYCHIATRY | QUETIAPINE TREATMENT | COMBAT VETERANS | SLEEP DISTURBANCES | RANDOMIZED CONTROLLED-TRIAL | MAJOR DEPRESSION | posttraumatic stress disorder | psychopharmacology | VENLAFAXINE EXTENDED-RELEASE | DOUBLE-BLIND | OPEN-LABEL TRIAL | ADJUNCTIVE THERAPY | Mianserin - adverse effects | Trazodone - therapeutic use | Antidepressive Agents, Second-Generation - adverse effects | Triazoles - adverse effects | Trazodone - adverse effects | Sleep Wake Disorders - drug therapy | Antipsychotic Agents - adverse effects | Humans | Mianserin - therapeutic use | Prazosin - therapeutic use | Antidepressive Agents, Second-Generation - therapeutic use | Mianserin - analogs & derivatives | Stress Disorders, Post-Traumatic - therapy | Anticonvulsants - adverse effects | Adrenergic alpha-1 Receptor Antagonists - therapeutic use | Antipsychotic Agents - therapeutic use | Prazosin - adverse effects | Stress Disorders, Post-Traumatic - drug therapy | Adrenergic alpha-1 Receptor Antagonists - adverse effects | Sleep Wake Disorders - etiology | Triazoles - therapeutic use | Serotonin Uptake Inhibitors - therapeutic use | Anticonvulsants - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Stress Disorders, Post-Traumatic - psychology | Sleep Wake Disorders - psychology | Stress Disorders, Post-Traumatic - complications | Antidepressive Agents, Tricyclic - therapeutic use | Antidepressive Agents, Tricyclic - adverse effects | Evidence Based Treatment | Treatment Effectiveness | PTSD (DSM-IV) | Drug Therapy | Practice Guideline
Journal Article